RxDoctor Payments Data

Sanjay Thekkeurumbil, MD

Colon & Rectal Surgery · Indianapolis, INNPI 1902065261

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,021 of the $3,362 with a category attached, or 60.1%. 20 manufacturers reported payments, led by Intuitive Surgical at 51.1% of the total. Reporting peaked in 2019 at $1,886 and has fallen 75.6% since, to $461 in 2025.

$3,362in general payments, 2019–2025

Across 87 payments — averaging $38.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • AbbVie$889
  • Johnson & Johnson$202
  • Kerecis Limited$98
  • Medtronic$97
  • Baxter Healthcare$45
  • plus $314 from 14 others

What the payments were for

  • Travel & lodging$34010%
  • Food & beverage$2,02160%
  • Education$1,00030%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,362 in reported general payments places this provider in the 55th percentile of 54 colon & rectal surgery providers in Indiana.

See all colon & rectal surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$67,688
Medicare patients
167
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lubiprostone12$951
Balsalazide Disodium11$830
Promethazine Hcl153$236
Metronidazole43$169
Ciprofloxacin Hcl12$134
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$122
Oxycodone Hcl18$121
Neomycin Sulfate22$119
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$75

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →